Effect of diet on multiple sclerosis patient

Effect of anti-inflammatory diet on inflammatory markers , oxidative stress , disability, fatigue and quality of life in relapsing-remitting multiple sclerosis patient

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171217037916N2

Enrollment

120

Registered

2018-09-05

Start date

2018-07-22

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: anti-inflammatory diet. Intervention 2: Control group: healthy diet recommendation.

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 20-50 years EDSS<5.5 Voluntary cooperation Clinical course of relapse-remitting

Exclusion criteria

Exclusion criteria: Use of a particular diet during the last 3 months before entering the study

Design outcomes

Primary

Measure	Time frame
Disability. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Expanded disability status scale.;Fatigue. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Modified fatigue impact scale.;Quality of life. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Multiple Sclerosis Questionnaire of Life-54.;Hs-CRP. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Laboratory kit.;IL17. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: ELISA.;IL4. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: ELISA.	—

Measure

Time frame

Disability. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Expanded disability status scale.;Fatigue. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Modified fatigue impact scale.;Quality of life. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Multiple Sclerosis Questionnaire of Life-54.;Hs-CRP. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Laboratory kit.;IL17. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: ELISA.;IL4. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: ELISA.

—

Secondary

Measure	Time frame
Total antioxidant capacity. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Laboratory kit.;Glutathione. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Laboratory kit.;Malondialdehyde. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Laboratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr, zohreh Mazloom

Shiraz University of Medical Sciences

z_mousavi@sums.ac.ir+98 71372510015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026